"Assessing Barriers to ADA Guideline Adherence"

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Agency for Healthcare Research and Quality (AHRQ).
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Agency for Healthcare Research and Quality (AHRQ)
ClinicalTrials.gov Identifier:
NCT00503464
First received: July 17, 2007
Last updated: July 18, 2012
Last verified: July 2012
  Purpose

This project involves a comprehensive assessment of barriers to diabetes guidelines adherence across 25 practices in the Crozer-Keystone primary care PBRN. A Barrier Assessment Tool (BAT) will be validated to correlate with provider and practice adherence to diabetes care guidelines. The network is part of the Crozer-Keystone Health System located in Delaware County, Pennsylvania, in the southeast quadrant of the Philadelphia metropolitan region.


Condition
Diabetes

Study Type: Observational
Official Title: "Assessing Barriers to American Diabetes Association Guideline Adherence"

Resource links provided by NLM:


Further study details as provided by Agency for Healthcare Research and Quality (AHRQ):

Study Start Date: September 2006
Detailed Description:

Study hypothesis: Questionnaire responses about perceived barriers to implementation of diabetes care recommendations, administered to primary care providers and staff, will be shown to correlate with that provider's and practice's success at implementing care guidelines.

Diabetes care in the U.S. consistently fails to meet recommended quality standards. Barriers impede the translation of evidence-based guidelines into sustainable practice. Few studies have considered multiple barriers, and there is a lack of evidence-based strategy in choosing interventions to overcome barriers. This study involves a comprehensive assessment of practice barriers to diabetes guidelines adherence across a primary care network. The BAT based upon a framework proposed by Cabana, et al (1999) will be validated to correlate with provider and practice adherence to diabetes care guidelines. A Diabetes Flow Sheet implemented in our Network to track adherence to guidelines will be assessed and correlated with measured barriers. This organizational strategy will support an evidence-based approach to quality initiative interventions. The BAT will be administered to practice team members: providers, support staff, and practice managers in our Network of 25 primary care practices. Five hypotheses are tested:

A: The BAT measures perceived barriers to adherence to diabetes guidelines, while showing adequate internal consistency and an identifiable subscale structure.

B: The BAT results inversely correlate with practice and provider adherence to ADA guidelines.

C: BAT scores will inversely correlate with use of the Diabetes Flow Sheet.

D: The BAT scores inversely correlate with clinical outcomes (glycemic and lipid control.)

E: Use of the Diabetes Flow Sheet correlates with higher provider and practice adherence to ADA guidelines.

The BAT would then provide the structure for comprehensive assessment of barriers. Study of the Crozer-Keystone PBRN is a real-world laboratory for research in the translation of evidence into diverse practices. The Network is optimally positioned to implement and study this organizational strategy.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Crozer-Keystone Health Network primary care (Internal Medicine and Family Medicine) providers and support staff in the 25 primary care practices.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00503464

Contacts
Contact: Anne M Allie, B.S. 610-579-3491 annemarie.allie@crozer.org

Locations
United States, Pennsylvania
Crozer-Keystone Health System Practice-Based Research Network Recruiting
Upland, Pennsylvania, United States, 19013
Contact: Anne M. Allie, B.S.    610-579-3491    annemarie.allie@crozer.org   
Principal Investigator: Mitchell A. Kaminski, M.D., M.B.A.         
Sponsors and Collaborators
Investigators
Principal Investigator: Mitchell A. Kaminski, M.D., M.B.A. Crozer-Keystone Health Network
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00503464     History of Changes
Other Study ID Numbers: #R03 HS016065-01, PAR-04-041
Study First Received: July 17, 2007
Last Updated: July 18, 2012
Health Authority: United States: Federal Government

Keywords provided by Agency for Healthcare Research and Quality (AHRQ):
guideline
adherence

Additional relevant MeSH terms:
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on October 30, 2014